FBInvestor
Stocks / Ginkgo Bioworks Holdings Inc
Institutional Ownership

Ginkgo Bioworks Holdings Inc

CUSIP 37611X209CL A NEWDNAQ1 2026

13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
9.5%
Max % of class reported
Institutional Holders
165
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

11 filings · latest Feb 5, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 5, 2026Baillie Gifford &Amp; Co13G/A4.9%2.39MSEC
2Nov 14, 2025Cascade Investment, L.L.C.13G/A7.5%3.62MSEC
3Jul 29, 2025The Vanguard Group13G5.1%2.38MSEC
4Jul 17, 2025Blackrock, Inc.13G6.5%3.00MSEC
5Feb 14, 2025Austin Che13G/A5.0%2.37MSEC
6Feb 14, 2025Reshma P. Shetty13D/A9.5%SEC
7Jan 30, 2025The Vanguard Group13G/A4.5%2.01MSEC
8Jan 10, 2025Ark Investment Management LLC13G/ASEC
9Nov 14, 2024Viking Global Investors LP13G/A8.3%3.58MSEC
10Nov 12, 2024Vanguard Group Inc13G/A6.0%2.61MSEC

1 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Ginkgo Bioworks Holdings Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →